Global Sustained Release Excipients Market Size, Trends & Analysis - Forecasts to 2028 By Product (Gelatin, Polymers, Minerals, Sugars, Alcohol, and Chitosan), By Technology (Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation, and Others), By Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The global sustained release excipients market is projected to grow at a CAGR of 8.6% from 2023 to 2028.
The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and pain management conditions is fuelling demand for sustained release drug delivery systems to provide long-term therapeutic effects. Advancements in pharmaceutical technology have enabled the development of novel excipients that enhance the performance of sustained release formulations, leading to their wider adoption. Sustained release excipients allow less frequent dosing and reduce fluctuations in drug levels, providing improved patient convenience and adherence to prescribed medications.
Increasing research and development activities in the pharmaceutical industry have led to the discovery and implementation of new excipients that are personalized for sustained release formulations. Numerous companies are currently underway to enhance the effectiveness, bioavailability, and patient adherence of oral drug therapies. To meet the increasing demands, various sustained-release oral drug delivery technologies have been introduced. For instance, a September 2021 publication in NCBI highlighted the potential use of gastro retentive drug delivery technologies, designed to keep dosage forms in the upper gastrointestinal tract. Utilizing sustained-release approaches, these technologies have the potential to improve patient compliance and therapeutic effectiveness by reducing the frequency of dosing.
Patent expirations of several branded drugs have created opportunities for generic drug manufacturers to develop their versions with sustained release formulations, driving the need for compatible excipients.
In March 2022, Hovione collaborated with Zerion Pharma in order to enhance its oral drug delivery toolkit product line, focusing on addressing the challenges associated with low drug solubility. This partnership aims to commercialize the technology and offer effective solutions for enhancing drug solubility in oral formulations.
Moreover, the paediatric population has unique requirements when it comes to oral drug delivery systems, which are currently lacking in the market. Customised delivery systems specifically designed for children are necessary to ensure safe and effective medication administration for this subset of the population.
Polymer segment is expected to hold the largest share in the market and the segment will continue to witness rapid growth in the global market over the forecast period. The growth is attributed to rising demand for sustained-release formulations that significantly contribute to increasing utilization of polymers in the pharmaceutical sector. Due to their favourable characteristics, polymers are being widely adopted as excipients in solid pharmaceutical formulations.
Pharmaceutical polymers have gained prominence due to their superior strength and extended shelf-life compared to other excipients in pharmaceutical preparations. Their evolution from simple gelatine shells to enhanced capsules allows controlled/sustained drug release, targeting specific sites. The increasing adoption of polyethylene glycol in formulations is driving significant growth of the segment.
Transdermal route is anticipated to be the fastest-growing segment in the market from 2023-2028. This is for the reason that it overcomes several limitations associated with oral and parenteral administration. Transdermal patches allow sustained drug release through the skin, avoiding issues related to gastrointestinal interactions with food and enzymatic degradation, making it a preferred alternative to oral delivery.
Oral drug segment is expected to hold largest share in the market. This is attributed to its convenience and preference as a drug delivery route, offering maximum active surface area for drug absorption compared to other methods. The use of excipients in formulating oral drugs for sustained release is common, and is rapidly gaining U.S. FDA approval for known molecules in such formulations. In June 2023, International Flavors & Fragrances, Inc. introduced new oral excipient including METHOCEL, in China to cater to the growing market demand.
The transdermal sustained delivery technology segment is anticipated to be the fastest-growing segment in the market from 2023-2028. It bypasses hepatic first-pass metabolism, reduces drug side effects, and enhances patient adherence. For instance, Corplex technology developed by Corium International, Inc. simplifies drug administration through the skin. As sustained release drug delivery systems gain wider acceptance, this segment is projected to capture a substantial share of the market revenue in the near future.
The target delivery segment is expected to hold largest share in the market. Targeted delivery involves delivering drugs specifically to the desired site of action, reducing the risk of drug toxicity in unintended areas. Sustained release drug delivery systems enhance patient adherence to medication, while targeted drug delivery technology localizes drugs, leading to consistent drug effects, stable circulating drug levels, and minimized adverse effects.
North America is expected to be the largest region in the market. This growth is attributed to increase in R&D efforts and the dominance of large pharmaceutical companies. Moreover, the region is expected to become more lucrative in the forecast period due to patent expirations, leading to the entry of generic drugs. The growth of the market in the region is also being aided by North American healthcare organisations working together to increase public awareness about chronic diseases and their treatment options.
Asia Pacific is projected to witness rapid growth during the forecast period. This growth can be attributed to a number of factors such as region's growing need for potent therapeutics, rapid development of the healthcare infrastructure, and rising prevalence of infectious diseases in the region. China is emerging as a lucrative market in Asia Pacific, attracting international excipient suppliers to establish production facilities and secure a substantial market share in terms of revenue generation.
BASF, International Flavors & Fragrances, Inc., Ashland Global, Evonik Industries, Croda International Plc, Gattefossé, Merck KGaA, Pfizer Inc., Sun Pharmaceutical Industries Ltd, and Novartis AG, among others are some of the key players operating in the global sustained release excipients market.
Please note: This is not an exhaustive list of companies profiled in the report.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics
3 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET OUTLOOK
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
4 GLOBAL SUSTAINED RELEASE EXCIPIENTSMARKET, BY PRODUCT TYPE
4.2 Sustained Release ExcipientsMarket: Product Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4.1 Gelatin Market Estimates and Forecast, 2020-2028 (USD Million)
4.5.1 Polymers Market Estimates and Forecast, 2020-2028 (USD Million)
4.6.1 Minerals Market Estimates and Forecast, 2020-2028 (USD Million)
4.7.1 Sugars Market Estimates and Forecast, 2020-2028 (USD Million)
4.8.1 Alcohol Market Estimates and Forecast, 2020-2028 (USD Million)
4.9.1 Chitosan Market Estimates and Forecast, 2020-2028 (USD Million)
5 GLOBAL SUSTAINED RELEASE EXCIPIENTSMARKET, BY TECHNOLOGY
5.2 Sustained Release ExcipientsMarket: Technology Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4.1 Targeted Delivery Market Estimates and Forecast, 2020-2028 (USD Million)
5.5.1 Micro Encapsulation Market Estimates and Forecast, 2020-2028 (USD Million)
5.6.1 Wurster Technique Market Estimates and Forecast, 2020-2028 (USD Million)
5.7.1 Transdermal Market Estimates and Forecast, 2020-2028 (USD Million)
5.8.1 Implants Market Estimates and Forecast, 2020-2028 (USD Million)
5.9.1 Coacervation Market Estimates and Forecast, 2020-2028 (USD Million)
5.10.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
6 GLOBAL SUSTAINED RELEASE EXCIPIENTSMARKET, BY ROUTE OF ADMINISTRATION
6.2 Sustained Release ExcipientsMarket: Route of Administration Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4.1 Oral Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.1 Intramuscular Market Estimates and Forecast, 2020-2028 (USD Million)
6.6.1 Subcutaneous Market Estimates and Forecast, 2020-2028 (USD Million)
6.7.1 Transdermal Market Estimates and Forecast, 2020-2028 (USD Million)
6.8.1 Vaginal Market Estimates and Forecast, 2020-2028 (USD Million)
6.9.1 Ophthalmic Market Estimates and Forecast, 2020-2028 (USD Million)
6.10.1 Intravenous Market Estimates and Forecast, 2020-2028 (USD Million)
6.11.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
7 GLOBAL SUSTAINED RELEASE EXCIPIENTSMARKET, BY REGION
7.2 North America Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.2.3 By Route of Administration
7.2.4.1 U.S. Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.1.3 By Route of Administration
7.2.4.2 Canada Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.2.3 By Route of Administration
7.2.4.3 Mexico Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.3.3 By Route of Administration
7.3 Europe Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.3.3 By Route of Administration
7.3.4.1 Germany Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.1.3 By Route of Administration
7.3.4.2 U.K. Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.2.3 By Route of Administration
7.3.4.3 France Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.3.3 By Route of Administration
7.3.4.4 Italy Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.4.3 By Route of Administration
7.3.4.5 Spain Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.5.3 By Route of Administration
7.2.4.6.3 By Route of Administration
7.2.4.7.3 By Route of Administration
7.4 Asia Pacific Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.3 By Route of Administration
7.4.4.1 China Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.1.3 By Route of Administration
7.4.4.2 Japan Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.2.3 By Route of Administration
7.4.4.3 India Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.3.3 By Route of Administration
7.4.4.4.3 By Route of Administration
7.4.4.5 Singapore Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.5.3 By Route of Administration
7.4.4.6 Malaysia Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.6.3 By Route of Administration
7.4.4.7 Thailand Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.7.3 By Route of Administration
7.4.4.8 Indonesia Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.8.3 By Route of Administration
7.4.4.9 Vietnam Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.9.3 By Route of Administration
7.4.4.10 Taiwan Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.10.3 By Route of Administration
7.4.4.11.3 By Route of Administration
7.5.3 By Route of Administration
7.5.4.1.3 By Route of Administration
7.5.4.2 U.A.E. Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.2.3 By Route of Administration
7.5.4.3 Israel Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.3.3 By Route of Administration
7.5.4.4.3 By Route of Administration
7.5.4.5.2 By Route of Administration
7.6.3 By Route of Administration
7.6.4.1 Brazil Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.1.3 By Route of Administration
7.6.4.2 Argentina Eaporative Air Cooler Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.2.3 By Route of Administration
7.6.4.3 Chile Sustained Release ExcipientsMarket Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.3.3 By Route of Administration
7.6.4.4.3 By Route of Administration
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.4.1.1 Business Description & Financial Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 International Flavors & Fragrances, Inc.
8.4.2.1 Business Description & Financial Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3.1 Business Description & Financial Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4.1 Business Description & Financial Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5.1 Business Description & Financial Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6.1 Business Description & Financial Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7.1 Business Description & Financial Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Sun Pharmaceutical Industries Ltd
8.4.8.1 Business Description & Financial Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9.1 Business Description & Financial Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10.1 Business Description & Financial Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11.1 Business Description & Financial Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9.1.2 Market Scope & Segmentation
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.4 Discussion Guide for Primary Participants
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
LIST OF TABLES
1 Global Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Mllion)
2 Gelatin Market, By Region, 2020-2028 (USD Mllion)
3 Polymers Market, By Region, 2020-2028 (USD Mllion)
4 Minerals Market, By Region, 2020-2028 (USD Mllion)
5 Sugars Market, By Region, 2020-2028 (USD Mllion)
6 alcohol Market, By Region, 2020-2028 (USD Mllion)
7 chitosan Market, By Region, 2020-2028 (USD Mllion)
8 Global Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Mllion)
9 Targeted Delivery Market, By Region, 2020-2028 (USD Mllion)
10 Micro Encapsulation Market, By Region, 2020-2028 (USD Mllion)
11 Wurster Technique Market, By Region, 2020-2028 (USD Mllion)
12 Transdermal Market, By Region, 2020-2028 (USD Mllion)
13 Implants Market, By Region, 2020-2028 (USD Mllion)
14 Coacervation Market, By Region, 2020-2028 (USD Mllion)
15 Others Market, By Region, 2020-2028 (USD Mllion)
16 Global Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Mllion)
17 Oral Market, By Region, 2020-2028 (USD Mllion)
18 Intramuscular Market, By Region, 2020-2028 (USD Mllion)
19 Subcutaneous Market, By Region, 2020-2028 (USD Mllion)
20 Transdermal Market, By Region, 2020-2028 (USD Mllion)
21 Vaginal Market, By Region, 2020-2028 (USD Mllion)
22 Ophthalmic Market, By Region, 2020-2028 (USD Mllion)
23 Intravenous Market, By Region, 2020-2028 (USD Mllion)
24 Others Market, By Region, 2020-2028 (USD Mllion)
25 Regional Analysis, 2020-2028 (USD Mllion)
26 North America Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
27 North America Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
28 North America Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
29 North America Sustained Release ExcipientsMarket, By Country, 2020-2028 (USD Million)
30 U.S Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
31 U.S Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
32 U.S Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
33 Canada Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
34 Canada Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
35 Canada Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
36 Mexico Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
37 Mexico Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
38 Mexico Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
39 Europe Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
40 Europe Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
41 Europe Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
42 Germany Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
43 Germany Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
44 Germany Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
45 U.K. Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
46 U.K. Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
47 U.K. Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
48 France Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
49 France Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
50 France Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
51 Italy Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
52 Italy Sustained Release ExcipientsMarket, By T End Use Type, 2020-2028 (USD Million)
53 Italy Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
54 Spain Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
55 Spain Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
56 Spain Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
57 Rest Of Europe Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
58 Rest Of Europe Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
59 Rest of Europe Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
60 Asia Pacific Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
61 Asia Pacific Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
62 Asia Pacific Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
63 Asia Pacific Sustained Release ExcipientsMarket, By Country, 2020-2028 (USD Million)
64 China Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
65 China Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
66 China Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
67 India Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
68 India Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
69 India Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
70 Japan Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
71 Japan Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
72 Japan Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
73 South Korea Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
74 South Korea Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
75 South Korea Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
76 Middle East and Africa Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
77 Middle East and Africa Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
78 Middle East and Africa Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
79 Middle East and Africa Sustained Release ExcipientsMarket, By Country, 2020-2028 (USD Million)
80 Saudi Arabia Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
81 Saudi Arabia Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
82 Saudi Arabia Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
83 UAE Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
84 UAE Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
85 UAE Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
86 Central and South America Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
87 Central and South America Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
88 Central and South America Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
89 Central and South America Sustained Release ExcipientsMarket, By Country, 2020-2028 (USD Million)
90 Brazil Sustained Release ExcipientsMarket, By Product Type, 2020-2028 (USD Million)
91 Brazil Sustained Release ExcipientsMarket, By Technology, 2020-2028 (USD Million)
92 Brazil Sustained Release ExcipientsMarket, By Route of Administration, 2020-2028 (USD Million)
93 BASF: Products & Services Offering
94 International Flavors & Fragrances, Inc.: Products & Services Offering
95 Ashland Global: Products & Services Offering
96 Evonik Industries: Products & Services Offering
97 Croda International Plc: Products & Services Offering
98 GATTEFOSSÉ: Products & Services Offering
99 Merck KGaA : Products & Services Offering
100 Sun Pharmaceutical Industries Ltd: Products & Services Offering
101 Novartis AG, Inc: Products & Services Offering
102 Pfizer Inc.: Products & Services Offering
103 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Sustained Release ExcipientsMarket Overview
2 Global Sustained Release ExcipientsMarket Value From 2020-2028 (USD Mllion)
3 Global Sustained Release ExcipientsMarket Share, By Product Type (2022)
4 Global Sustained Release ExcipientsMarket Share, By Technology (2022)
5 Global Sustained Release ExcipientsMarket Share, By Route of Administration (2022)
6 Global Sustained Release ExcipientsMarket, By Region (Asia Pacific Market)
7 Technological Trends In Global Sustained Release ExcipientsMarket
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Sustained Release ExcipientsMarket
11 Impact Of Challenges On The Global Sustained Release ExcipientsMarket
12 Porter’s Five Forces Analysis
13 Global Sustained Release ExcipientsMarket: By Product Type Scope Key Takeaways
14 Global Sustained Release ExcipientsMarket, By Product Type Segment: Revenue Growth Analysis
15 Gelatin Market, By Region, 2020-2028 (USD Mllion)
16 Polymers Market, By Region, 2020-2028 (USD Mllion)
17 Minerals Market, By Region, 2020-2028 (USD Mllion)
18 Sugars Market, By Region, 2020-2028 (USD Mllion)
19 Alcohol Market, By Region, 2020-2028 (USD Mllion)
20 Chitosan Market, By Region, 2020-2028 (USD Mllion)
21 Global Sustained Release ExcipientsMarket: By Technology Scope Key Takeaways
22 Global Sustained Release ExcipientsMarket, By Technology Segment: Revenue Growth Analysis
23 Targeted Delivery Market, By Region, 2020-2028 (USD Mllion)
24 Micro Encapsulation Market, By Region, 2020-2028 (USD Mllion)
25 Global Sustained Release ExcipientsMarket: By Route of Administration Scope Key Takeaways
26 Global Sustained Release ExcipientsMarket, By Route of Administration Segment: Revenue Growth Analysis
27 Oral Market, By Region, 2020-2028 (USD Mllion)
28 Intramuscular Market, By Region, 2020-2028 (USD Mllion)
29 Subcutaneous Market, By Region, 2020-2028 (USD Mllion)
30 Transdermal Market, By Region, 2020-2028 (USD Mllion)
31 Vaginal Market, By Region, 2020-2028 (USD Mllion)
32 Ophthalmic Market, By Region, 2020-2028 (USD Mllion)
33 Intravenous Market, By Region, 2020-2028 (USD Mllion)
34 Others Market, By Region, 2020-2028 (USD Mllion)
35 Regional Segment: Revenue Growth Analysis
36 Global Sustained Release ExcipientsMarket: Regional Analysis
37 North America Sustained Release ExcipientsMarket Overview
38 North America Sustained Release ExcipientsMarket, By Product Type
39 North America Sustained Release ExcipientsMarket, By Technology
40 North America Sustained Release ExcipientsMarket, By Route of Administration
41 North America Sustained Release ExcipientsMarket, By Country
42 U.S. Sustained Release ExcipientsMarket, By Product Type
43 U.S. Sustained Release ExcipientsMarket, By Technology
44 U.S. Sustained Release ExcipientsMarket, By Route of Administration
45 Canada Sustained Release ExcipientsMarket, By Product Type
46 Canada Sustained Release ExcipientsMarket, By Technology
47 Canada Sustained Release ExcipientsMarket, By Route of Administration
48 Mexico Sustained Release ExcipientsMarket, By Product Type
49 Mexico Sustained Release ExcipientsMarket, By Technology
50 Mexico Sustained Release ExcipientsMarket, By Route of Administration
51 Four Quadrant Positioning Matrix
52 Company Market Share Analysis
53 BASF: Company Snapshot
54 BASF: SWOT Analysis
55 BASF: Geographic Presence
56 International Flavors & Fragrances, Inc.: Company Snapshot
57 International Flavors & Fragrances, Inc.: SWOT Analysis
58 International Flavors & Fragrances, Inc.: Geographic Presence
59 Ashland Global: Company Snapshot
60 Ashland Global: SWOT Analysis
61 Ashland Global: Geographic Presence
62 Evonik Industries: Company Snapshot
63 Evonik Industries: Swot Analysis
64 Evonik Industries: Geographic Presence
65 Croda International Plc: Company Snapshot
66 Croda International Plc: SWOT Analysis
67 Croda International Plc: Geographic Presence
68 GATTEFOSSÉ: Company Snapshot
69 GATTEFOSSÉ: SWOT Analysis
70 GATTEFOSSÉ: Geographic Presence
71 Merck KGaA : Company Snapshot
72 Merck KGaA : SWOT Analysis
73 Merck KGaA : Geographic Presence
74 Sun Pharmaceutical Industries Ltd: Company Snapshot
75 Sun Pharmaceutical Industries Ltd: SWOT Analysis
76 Sun Pharmaceutical Industries Ltd: Geographic Presence
77 Novartis AG, Inc.: Company Snapshot
78 Novartis AG, Inc.: SWOT Analysis
79 Novartis AG, Inc.: Geographic Presence
80 Pfizer Inc.: Company Snapshot
81 Pfizer Inc.: SWOT Analysis
82 Pfizer Inc.: Geographic Presence
83 Other Companies: Company Snapshot
84 Other Companies: SWOT Analysis
85 Other Companies: Geographic Presence
The Global Sustained Release Excipients Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Sustained Release Excipients Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS